Enterprise Value
-11.94M
Cash
25.62M
Avg Qtr Burn
-25.53M
Short % of Float
0.59%
Insider Ownership
0.04%
Institutional Own.
11.94%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 3 Data readout | ||
TNX-1900 Details Psychiatric disorder | Phase 2 Data readout | |
TNX-1900 Details Obesity | Phase 2 Data readout | |
TNX-1900 Details Social Anxiety Disorder | Phase 2 Data readout | |
TNX-601 Details Major depressive disorder | Phase 2 Data readout | |
TNX-1900 Details Migraines | Phase 2 Data readout | |
TNX-102 SL Details Sleeping disorder, Post-traumatic stress disorder | Phase 2 Update | |
TNX-102 SL Details COVID-19 | Phase 2 Update | |
TNX-1300 Details Cocaine overdose / intoxication | Phase 2 Initiation | |
TNX-1500 Details Kidney transplantation, Graft-versus-host disease , Hematopoietic cell transplantation | Phase 1 Data readout | |
TNX-102 SL Details Agitation, Alzheimer's disease | Failed Discontinued | |
TNX-102 SL Details Alcohol dependence | Failed Discontinued |